Related Experiment Video

Updated: Apr 22, 2026

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
09:09

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

24.1K

Role of alveolar macrophages in chronic obstructive pulmonary disease

Ross Vlahos1, Steven Bozinovski1

  • 1Department of Pharmacology and Therapeutics, Lung Health Research Centre, The University of Melbourne , Parkville, VIC , Australia.

Frontiers in Immunology
|October 14, 2014
PubMed

Insights

Alveolar macrophages (AMs) are crucial for lung health, originating from fetal monocytes and self-renewing via specific signaling. In chronic obstructive pulmonary disease (COPD), AM dysfunction impairs inflammation resolution, leading to persistent lung issues.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Cell Biology

Background:

  • Alveolar macrophages (AMs) are vital immune cells in the lungs, originating from fetal monocytes and self-renewing through GM-CSF and CSF-1 signaling.
  • Peripheral blood monocytes can also replenish lung macrophages, but this is stimulus-dependent.
  • AMs are critical for immune responses and resolving inflammation via efferocytosis.

Purpose of the Study:

  • To investigate the role of alveolar macrophages in chronic obstructive pulmonary disease (COPD).
  • To explore the mechanisms behind impaired inflammation resolution in COPD.
  • To discuss endogenous mediators contributing to M1/M2 macrophage imbalance in COPD.

Main Methods:

  • Review of existing literature on alveolar macrophage biology and COPD.
  • Analysis of macrophage phenotypes and transcriptomic profiles in COPD.
  • Discussion of signaling pathways and endogenous mediators involved.

Main Results:

  • In COPD, airway macrophages accumulate and deviate from the M1/M2 dichotomy.
  • A skewed transcriptome favoring M2 (wound-healing) markers indicates impaired inflammation resolution.
  • Perturbation of efferocytosis and macrophage balance contributes to COPD pathology.

Conclusions:

  • Alveolar macrophage dysfunction, characterized by M2 skewing and impaired efferocytosis, is central to COPD pathogenesis.
  • Endogenous mediators likely disrupt the M1/M2 balance, hindering inflammation resolution and lung homeostasis.
  • Understanding these mechanisms is crucial for developing targeted COPD therapies.
Keywords:
alveolar macrophagechronic obstructive pulmonary diseaseefferocytosislung inflammationoxidative stressresolution

More Related Videos

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure08:54

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

8.6K
Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice11:20

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice

Published on: March 2, 2019

11.0K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
23
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
19
Alveoli and Alveolar Ducts01:26

Alveoli and Alveolar Ducts

The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
5.7K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K